GSK plc
GSK
#225
Rank
NZ$183.83 B
Marketcap
NZ$91.71
Share price
2.48%
Change (1 day)
8.97%
Change (1 year)

EPS for GSK plc (GSK)

EPS in 2023 (TTM): NZ$5.66

According to GSK plc's latest financial reports the company's current EPS (TTM) is NZ$5.12. In 2022 the company made an earnings per share (EPS) of NZ$15.08 an increase over its 2021 EPS that were of NZ$5.32.

EPS history for GSK plc from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ$5.66-62.47%
2022NZ$15.08183.39%
2021NZ$5.32-17.83%
2020NZ$6.4821.82%
2019NZ$5.3223.91%
2018NZ$4.29141.48%
2017NZ$1.7864.6%
2016NZ$1.08-90.64%
2015NZ$11.53178.14%
2014NZ$4.15-48.16%
2013NZ$8.0022.63%
2012NZ$6.52-11.32%
2011NZ$7.35230.25%
2010NZ$2.23-70.98%
2009NZ$7.676.76%
2008NZ$7.19-15.14%
2007NZ$8.477.82%
2006NZ$7.8619.61%
2005NZ$6.5718.56%
2004NZ$5.540.36%
2003NZ$5.5250.39%
2002NZ$3.6731.13%
2001NZ$2.80-25.43%
2000NZ$3.7531.58%
1999NZ$2.851.05%
1998NZ$2.82-0.98%
1997NZ$2.85-10.07%
1996NZ$3.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$9.34 82.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.35-73.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.38-33.87%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$1.77-65.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$11.88 132.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$1.12-78.10%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
NZ-$0.57-111.12%๐Ÿ‡บ๐Ÿ‡ธ USA